MDPI webinar – Role of Nrf2 in Neurodegeneration: Novel Molecular Mechanisms and Therapeutic Approaches
On October 16, the coordinator of the NRF24AD project, Manuela García López, will participate in a free webinar organized by the “Multidisciplinary Digital Publishing Institute”
Interview with Antonio Cuadrado
“New therapeutic strategies in neurodegenerative diseases”, interview with one of the main researchers of our project, Antonio Cuadrado. An initiative from the UAM Foundation to
Doctoral Thesis – Sheila Abril
We continue increasing the number of doctors in the NRF24AD project. This time it was Sheila Abril’s turn, who presented her doctoral thesis entitled Novel
SFN Congress 19-23 Oct, Chicago
Several members of GT1 are attending the annual congress of the Society for Neuroscience, held this week in the city of Chicago. This year is
PhD Thesis Natalia Robledinos and Clara Herrera
On October 11, Natalia Robledinos (GT2 group) and Clara Herrera (GT3 group) defended their doctoral thesis entitled “Orchestration of the neural stem cell fate by
V Scientific Meeting
After the summer holidays, we return to the Project with a consortium meeting to catch up on the latest results obtained in each work group
2019 Lilly Award for Early-Stage Researchers
On July 8, Clara Herrera received the Lilly Award for early-stage researchers from the Spanish Society of Therapeutic Chemistry (SEQT) as recognition to her work
Farmadrid 28
On June 26, the 28th edition of Farmadrid took place at La Princesa University Hospital. These annual meetings have been held since 1991, with the
EFMC-ACSMEDI MedChem Frontiers 2019 Congress
Sheila Abril, member of GT1, attended the EFMC-ACSMEDI MedChem Frontiers 2019 congress held in Krakow (Poland), on June 10-13. The American Chemical Society and the
New type of dementia identified
A team of researchers from different universities and research centers form the United States, Japan, Australia, Sweden, United Kingdom and Austria led by Dr. Peter
IV Scientific Meeting
Yesterday we celebrated the IV Scientific Meeting of the project. Eric del Sastre, Felipe Franco, Raquel Fernández and Santiago Stabile presented the latest results of
GT3 attended the 63rd edition of the Biophysical Society Annual Congress
The group from the Institute of Medical Chemistry (GT3) attended last march the 63rd edition of the Annual Congress of the Biophysical Society, held in
Patrycja Michalska’s doctoral thesis
On April 5, 2019 Patrycja Michalska Dziama, member of the NRF24AD project (GT1), defended her doctoral thesis entitled “Novel Nrf2 inducers with multitarget activities for
First presentation of the “Teófilo Hernando” Forum of Young Researchers by Dr. Rafael León
Dr. Rafaél León made the first presentation of the “Teófilo Hernando” Forum of Young Researchers, organized by the Teófilo Hernando Foundation and the Royal National
Transcription factor NRF2: New opportunities for pharmaceutical innovations in chronic diseases.
Antonio Cuadrado, Ana I. Rojo, and Albena Dinkova-Kostova were the organizers of this showcase meeting about NRF2, held in Madrid on April 2018. The aim